{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:13:08Z","timestamp":1787775188542,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.dld.2021.02.017","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T22:07:13Z","timestamp":1616796433000},"page":"830-834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia"],"prefix":"10.1016","volume":"53","author":[{"given":"Lucia","family":"Cococcioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licia","family":"Pensabene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"El-Khouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibongile","family":"Chadokufa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Saliakellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fevronia","family":"Kiparissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2021.02.017_bib0001","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ibd.21740","article-title":"Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease","volume":"18","author":"Goodhand","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2021.02.017_bib0002","doi-asserted-by":"crossref","unstructured":"Wiskin AE, Fleming BJ, Wootton SA, et al. Anemia and iron deficiency in children with inflammatory bowel disease. J. Crohn's Colitis 2012;6:687\u201391.","DOI":"10.1016\/j.crohns.2011.12.001"},{"key":"10.1016\/j.dld.2021.02.017_bib0003","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/MPG.0000000000002002","article-title":"Anemia in pediatric inflammatory bowel disease","volume":"67","author":"Aljomah","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2021.02.017_bib0004","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/ecco-jcc\/jjv242","article-title":"Serum hepcidin and iron absorption in paediatric inflammatory bowel disease","volume":"10","author":"Martinelli","year":"2016","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.dld.2021.02.017_bib0005","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1182\/blood-2008-12-195651","article-title":"Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications","volume":"113","author":"Theurl","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.dld.2021.02.017_bib0006","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.crohns.2014.01.011","article-title":"Iron treatment and inflammatory bowel disease: what happens in real practice?","volume":"8","author":"Lugg","year":"2014","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.dld.2021.02.017_bib0007","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/CEG.S43493","article-title":"Iron deficiency anemia in patients with inflammatory bowel disease","volume":"6","author":"Goldberg","year":"2013","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.dld.2021.02.017_bib0008","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1046\/j.1365-2036.2000.00828.x","article-title":"Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis","volume":"14","author":"Millar","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2021.02.017_bib0009","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/gutjnl-2015-309940","article-title":"Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD","volume":"66","author":"Lee","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.dld.2021.02.017_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202460","article-title":"Oral iron exacerbates colitis and influences the intestinal microbiome","volume":"13","author":"Mahalhal","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2021.02.017_bib0011","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.crohns.2011.09.010","article-title":"Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis J","volume":"6","author":"Lee","year":"2012","journal-title":"Crohn's Colitis"},{"key":"10.1016\/j.dld.2021.02.017_bib0012","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/apt.15327","article-title":"Randomised clinical trial: intravenous vs oral iron for the treatment of anemia after acute gastrointestinal bleeding","volume":"50","author":"Ferrer-Barcel\u00f3","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2021.02.017_bib0013","doi-asserted-by":"crossref","first-page":"e2308","DOI":"10.1097\/MD.0000000000002308","article-title":"Intravenous versus oral iron for the treatment of anemia in inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials","volume":"95","author":"Bonovas","year":"2016","journal-title":"Med (Baltimore)"},{"key":"10.1016\/j.dld.2021.02.017_bib0014","doi-asserted-by":"crossref","unstructured":"A.U. Dignass, C. Gasche, D. Bettenworth, et al. European consensus on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. J Crohn's Colitis 2015;9:211\u201322.","DOI":"10.1093\/ecco-jcc\/jju009"},{"key":"10.1016\/j.dld.2021.02.017_bib0015","unstructured":"Vifor Pharma UK Limited. Ferinject (ferric carboxymaltose): UK summary of product characteristics. 2019, (n.d.)."},{"key":"10.1016\/j.dld.2021.02.017_bib0016","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40265-018-0885-7","article-title":"Ferric carboxymaltose: a review in iron deficiency","volume":"78","author":"Scott","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.dld.2021.02.017_bib0017","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.gastro.2011.06.005","article-title":"FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease","volume":"141","author":"Evstatiev","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.02.017_bib0018","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3109\/00365521.2013.819442","article-title":"Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life","volume":"48","author":"Befrits","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2021.02.017_bib0019","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/apt.14043","article-title":"Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anemia in patients with inflammatory bowel disease","volume":"45","author":"Aksan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2021.02.017_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167146","article-title":"Choice of high-dose intravenous iron preparation determines hypophosphatemia risk","volume":"11","author":"Schaefer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2021.02.017_bib0021","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/apt.15386","article-title":"Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside","volume":"50","author":"Detlie","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2021.02.017_bib0022","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jpeds.2016.09.053","article-title":"Intravenous ferric carboxymaltose in children with iron deficiency anemia who respond poorly to oral iron","volume":"180","author":"Powers","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2021.02.017_bib0023","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1471-230X-14-184","article-title":"Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases","volume":"14","author":"Laass","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2021.02.017_bib0024","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/bcp.13493","article-title":"Safety and efficacy of parenteral iron in children with inflammatory bowel disease","volume":"84","author":"Papadopoulos","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dld.2021.02.017_bib0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpeds.2017.01.041","article-title":"Safety and efficacy of ferric carboxymaltose in children and adolescents with iron deficiency anemia","volume":"184","author":"Mantadakis","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2021.02.017_bib0026","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00431-017-2995-8","article-title":"Retrospective review of effectiveness and safety of intravenous ferric carboxymaltose given to children with iron deficiency anemia in one UK tertiary centre","volume":"176","author":"Tan","year":"2017","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.dld.2021.02.017_bib0027","doi-asserted-by":"crossref","first-page":"28","DOI":"10.21037\/tp.2019.01.01","article-title":"Ferric carboxymaltose in the treatment of iron deficiency in pediatric inflammatory bowel disease","volume":"8","author":"Carman","year":"2019","journal-title":"Transl Pediatr"},{"key":"10.1016\/j.dld.2021.02.017_bib0028","series-title":"Nelson \u2013 Texttbook of Pediatrics","first-page":"366","article-title":"Phosphorus","author":"Greenbaum","year":"2016"},{"key":"10.1016\/j.dld.2021.02.017_bib0029","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.dld.2007.07.168","article-title":"Research and clinical challenges in paediatric inflammatory bowel disease","volume":"40","author":"Bousvaros","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2021.02.017_bib0030","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.3748\/wjg.15.4666","article-title":"Intravenous iron in inflammatory bowel disease","volume":"15","author":"Munoz","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.dld.2021.02.017_bib0031","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/ajg.2009.114","article-title":"Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment","volume":"104","author":"Kulnigg","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2021.02.017_bib0032","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:17:02Z","timestamp":1761625022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865821000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1590865821000852"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2021.02.017","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2021.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}